Oral nicotinamide mononucleotide (NMN) to treat chronic insomnia: protocol for the multicenter, randomized, double-blinded, placebo-controlled trial

BACKGROUND: The treatment of insomnia, which is the most common sleep disorder, includes drug and behavioral treatment, but each treatment measure has its limitations. So new treatment method needs to be taken to improve the treatment effect. MN supplementation is a potential promising new method fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Xiangyang, Li, Junhua, Xu, Sanping, Li, Xueying, Wang, Xicheng, Li, Yongli, Huang, Yan, Liu, Shaohui, Zeng, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10193321/
https://www.ncbi.nlm.nih.gov/pubmed/37202819
http://dx.doi.org/10.1186/s13063-023-07351-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10193321/
https://www.ncbi.nlm.nih.gov/pubmed/37202819
http://dx.doi.org/10.1186/s13063-023-07351-8

Ejemplares similares